Apiam Animal Health Limited (ASX:AHX)
Australia · Delayed Price · Currency is AUD 0.8750
+0.0050 (0.57%)
Inactive · Last trade price on Feb 6, 2026
Apiam Animal Health Ratios and Metrics
Market cap in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Feb '26 Feb 5, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 166 | 96 | 63 | 92 | 116 | 127 | |
Market Cap Growth | 118.86% | 52.80% | -31.81% | -20.66% | -8.72% | 136.36% |
Enterprise Value | 266 | 195 | 166 | 179 | 197 | 183 |
Last Close Price | 0.78 | 0.45 | 0.29 | 0.41 | 0.55 | 0.74 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Feb '26 Feb 5, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
PE Ratio | 198.91 | 114.96 | 12.69 | 40.32 | 24.94 | 25.17 |
Forward PE | - | 4.92 | 4.92 | 9.29 | 12.23 | 17.33 |
PS Ratio | 0.80 | 0.46 | 0.31 | 0.48 | 0.74 | 1.00 |
PB Ratio | 1.37 | 0.79 | 0.51 | 0.78 | 1.07 | 1.57 |
P/FCF Ratio | 14.11 | 8.14 | 4.44 | 9.61 | 10.80 | 14.16 |
P/OCF Ratio | 9.40 | 5.42 | 3.32 | 5.28 | 7.70 | 9.26 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Feb '26 Feb 5, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
EV/Sales Ratio | 1.28 | 0.94 | 0.81 | 0.93 | 1.25 | 1.45 |
EV/EBITDA Ratio | 10.71 | 10.07 | 8.57 | 13.77 | 15.38 | 15.12 |
EV/EBIT Ratio | 21.39 | 15.70 | 13.40 | 25.96 | 25.34 | 22.30 |
EV/FCF Ratio | 22.62 | 16.61 | 11.75 | 18.72 | 18.40 | 20.45 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Feb '26 Feb 5, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Debt / Equity Ratio | 0.85 | 0.85 | 0.83 | 0.83 | 0.58 | 0.68 |
Debt / EBITDA Ratio | 4.13 | 4.13 | 4.18 | 5.73 | 3.93 | 3.76 |
Debt / FCF Ratio | 8.73 | 8.73 | 7.22 | 10.27 | 5.92 | 6.15 |
Net Debt / Equity Ratio | 0.83 | 0.83 | 0.82 | 0.81 | 0.56 | 0.65 |
Net Debt / EBITDA Ratio | 5.16 | 5.16 | 5.17 | 7.31 | 4.72 | 4.37 |
Net Debt / FCF Ratio | 8.51 | 8.51 | 7.09 | 9.93 | 5.65 | 5.91 |
Asset Turnover | 0.81 | 0.81 | 0.82 | 0.86 | 0.88 | 0.84 |
Inventory Turnover | 10.47 | 10.47 | 10.33 | 9.17 | 7.26 | 5.99 |
Quick Ratio | 0.45 | 0.45 | 0.45 | 0.52 | 0.57 | 0.64 |
Current Ratio | 0.95 | 0.95 | 0.95 | 1.04 | 1.25 | 1.37 |
Return on Equity (ROE) | 0.71% | 0.71% | 4.09% | 1.92% | 4.79% | 6.63% |
Return on Assets (ROA) | 3.04% | 3.04% | 3.08% | 1.93% | 2.73% | 3.43% |
Return on Invested Capital (ROIC) | 1.70% | 1.70% | 3.95% | 2.47% | 3.60% | 4.65% |
Return on Capital Employed (ROCE) | 5.60% | 5.60% | 5.60% | 3.20% | 4.60% | 6.20% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Feb '26 Feb 5, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Earnings Yield | 0.50% | 0.87% | 7.88% | 2.48% | 4.01% | 3.97% |
FCF Yield | 7.09% | 12.29% | 22.53% | 10.40% | 9.26% | 7.06% |
Dividend Yield | 2.29% | 4.40% | 6.98% | - | 2.90% | 3.23% |
Payout Ratio | 313.82% | 313.82% | 26.81% | 29.56% | 50.79% | 38.60% |
Buyback Yield / Dilution | -2.66% | -2.66% | -2.38% | -28.68% | -13.16% | -6.75% |
Total Shareholder Return | -0.38% | 1.74% | 4.60% | -28.68% | -10.26% | -3.52% |